Thursday, November 19, 2015
Channel stuffing by Valeant in Europe confirmed
This was (correctly) denied by Valeant who noted that they could not use specialty pharmacies to stuff the channel as the sale by a specialty pharmacy was only recognised by Valeant when the end customer was identified (and the drugs effectively sold to the end consumer).
It turns out that specialty pharmacy (and its attendant issues of ripping off insurance companies) is common at Valeant. It extends well beyond Philidor (as I will demonstrate in a future post).
In other words it is unlikely the channel is stuffed at all in America. But insurance copayment issues are far more widespread than Valeant asserts.
Yet receivable levels at Valeant are fairly high which leaves open the possibility that the channel was stuffed in places other than America.
This is now confirmed.
The Slovenian business press have done a fabulous job tracking down the stuffed warehouses in Slovenia. It is the front story on the main Slovenian business website (link) and they have kindly reproduced the story in English (link).
With a few forthcoming speciality finance scandals and confirmed channel stuffing this is getting uglier by the minute.
PS. Letter to Valeant longs (ie tragics)...
Dear former winners,
Valeant owns the big branded analgesic business in Russia (one example). Branded versus unbranded paracetamol/acetaminophen etc.
This sort of stuff is economically sensitive. No-name but identical products sell on the same shelves at 10% of the cost of the branded stuff.
Did you ever wonder why the sales of this did not fall in Russia and Eastern Europe given the economic issues there?
That is right - they stuffed the channel.
Keep your spirits up.
It is only (your clients') money.
The content contained in this blog represents the opinions of Mr. Hempton. You should assume Mr. Hempton and his affiliates have positions in the securities discussed in this blog, and such beneficial ownership can create a conflict of interest regarding the objectivity of this blog. Statements in the blog are not guarantees of future performance and are subject to certain risks, uncertainties and other factors. Certain information in this blog concerning economic trends and performance is based on or derived from information provided by third-party sources. Mr. Hempton does not guarantee the accuracy of such information and has not independently verified the accuracy or completeness of such information or the assumptions on which such information is based. Such information may change after it is posted and Mr. Hempton is not obligated to, and may not, update it. The commentary in this blog in no way constitutes a solicitation of business, an offer of a security or a solicitation to purchase a security, or investment advice. In fact, it should not be relied upon in making investment decisions, ever. It is intended solely for the entertainment of the reader, and the author. In particular this blog is not directed for investment purposes at US Persons.